The trial mooted by Telangana based, Bharat Biotech will be conducted in partnership with ICMR.
Phase 3 trials will involve 26,000 volunteers across 25 locations in India. The Clinical Trials Registry- India (CTRI) registered trial has been approved by the Drugs Controller General of India. It awaits approval of the institutional ethics committee of GMC and People’s university, according to CTRI.
Teams from ICMR and vaccine manufacture, conducted inspections at Gandhi Medical College and People’s Medical College in Bhopal. The countdown to the vaccine trial will begin as soon as the final agreement is made, said sources.